1-5 of 5
Bert Bravenboer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study

Nick Wlazlo, Marleen M.J. van Greevenbroek, Isabel Ferreira, Edith J.M. Feskens, Carla J.H. van der Kallen, Casper G. Schalkwijk, Bert Bravenboer, Coen D.A. Stehouwer
Journal: Diabetes Care
Diabetes Care 2014;37(7):1900–1909
https://doi.org/10.2337/dc13-2804
Published: 12 June 2014
View article titled, Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study
Open the PDF for Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study in another window
Includes: Supplementary data
Journal Articles

Iron Metabolism Is Associated With Adipocyte Insulin Resistance and Plasma Adiponectin: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study

Nick Wlazlo, MD, Marleen M.J. van Greevenbroek, PHD, Isabel Ferreira, PHD, Eugene H.J.M. Jansen, PHD, Edith J.M. Feskens, PHD, Carla J.H. van der Kallen, PHD, Casper G. Schalkwijk, PHD, Bert Bravenboer, MD, Coen D.A. Stehouwer, MD
Journal: Diabetes Care
Diabetes Care 2013;36(2):309–315
https://doi.org/10.2337/dc12-0505
Published: 17 January 2013
View article titled, Iron Metabolism Is Associated With Adipocyte Insulin Resistance and Plasma Adiponectin: <subtitle>The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study</subtitle>
Open the PDF for Iron Metabolism Is Associated With Adipocyte Insulin Resistance and Plasma Adiponectin: <subtitle>The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct Pathways: The Hoorn Study

Hanneke J.B.H. Beijers, MD, Isabel Ferreira, PHD, Bert Bravenboer, MD, PHD, Jacqueline M. Dekker, PHD, Giel Nijpels, MD, PHD, Robert J. Heine, MD, PHD, Coen D.A. Stehouwer, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(9):1698–1703
https://doi.org/10.2337/dc08-1544
Published: 29 June 2009
View article titled, Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct Pathways: <subtitle>The Hoorn Study</subtitle>
Open the PDF for Microalbuminuria and Cardiovascular Autonomic Dysfunction Are Independently Associated With Cardiovascular Mortality: Evidence for Distinct Pathways: <subtitle>The Hoorn Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Is the Corrected QT Interval a Reliable Indicator of the Severity of Diabetic Autonomic Neuropathy?

Bert Bravenboer, MD, Peter-Henk Hendriksen, PHD, Liam P Oey, PHD, William-Hwndrik Gispen, PHD, Alexander C Van Huffelen, PHD, D William Erkelens, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(9):1249–1253
https://doi.org/10.2337/diacare.16.9.1249
Published: 01 September 1993
View article titled, Is the Corrected QT Interval a Reliable Indicator of the Severity of Diabetic Autonomic Neuropathy?
Open the PDF for Is the Corrected QT Interval a Reliable Indicator of the Severity of Diabetic Autonomic Neuropathy? in another window
Journal Articles

Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients

Rutgert Bianchi, MD, Vivian Bongers, Bert Bravenboer, MD, D Willem Erkelens, MD
Journal: Diabetes Care
Diabetes Care 1993;16(4):557–559
https://doi.org/10.2337/diacare.16.4.557
Published: 01 April 1993
View article titled, Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients
Open the PDF for Effects of Benfluorex on Insulin Resistance and Lipid Metabolism in Obese Type II Diabetic Patients in another window